tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMVT is currently covered by 14 analysts with an average price target of $27.08. This is a potential upside of $13.2 (95.1%) from yesterday's end of day stock price of $13.88.
Immunovant 's activity chart (see below) currently has 76 price targets and 106 ratings on display. The stock rating distribution of IMVT is 98.15% BUY and 1.85% HOLD.
Analysts average stock forecasts to be materialized ratio is 59.01% with an average time for these price targets to be met of 179.53 days.
Highest price target for IMVT is $53, Lowest price target is $20, average price target is $43.82.
Most recent stock forecast was given by JASON GERBERRY from BAML on 20-Mar-2025. First documented stock forecast 07-Jan-2020.
Currently out of the existing stock ratings of IMVT, 53 are a BUY (98.15%), 1 are a HOLD (1.85%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$33
$17.2 (108.86%)
$45
1 months 18 days ago
(20-Mar-2025)
1/3 (33.33%)
$13.31 (67.60%)
126
Buy
1 months 18 days ago
(20-Mar-2025)
3/7 (42.86%)
$24.48 (125.41%)
119
Buy
$51
$35.2 (222.78%)
$51
1 months 19 days ago
(19-Mar-2025)
11/20 (55%)
$32.12 (170.13%)
268
Hold
$20
$4.2 (26.58%)
$32
2 months 5 days ago
(03-Mar-2025)
6/6 (100%)
$-0.6 (-2.91%)
95
Buy
$45
$29.2 (184.81%)
$48
4 months 19 days ago
(19-Dec-2024)
4/8 (50%)
$19.34 (75.37%)
371
What is IMVT (Immunovant ) average time for price targets to be met?
Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?
Which analyst has the most public recommendations on IMVT (Immunovant )?
Which analyst is the currently most bullish on IMVT (Immunovant )?
Which analyst is the currently most reserved on IMVT (Immunovant )?
